PFKFB2
Synthesis and degradation of fructose 2,6-bisphosphate. In the C-terminal section; belongs to the phosphoglycerate mutase family. Heart. 2 alternatively spliced human isoforms have been reported. Note: This description may include information from UniProtKB.
|
Protein type: Carbohydrate Metabolism - fructose and mannose; EC 2.7.1.105; EC 3.1.3.46; Kinase, other; Motility/polarity/chemotaxis; Phosphatase (non-protein) |
Chromosomal Location of human Ortholog: 1q32.1 |
Cellular Component:
cytosol; nucleoplasm
|
Molecular Function:
6-phosphofructo-2-kinase activity; ATP binding; fructose-2,6-bisphosphate 2-phosphatase activity; protein binding; protein kinase binding
|
Biological Process:
carbohydrate phosphorylation; fructose 2,6-bisphosphate metabolic process; fructose metabolic process; glucose catabolic process; glycolytic process; lactate metabolic process; positive regulation of glucokinase activity; positive regulation of insulin secretion; response to glucose
|
Reference #:
O60825
(UniProtKB)
|
Alt. Names/Synonyms: 6-phosphofructo-2-kinase; 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 2; 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 2; 6PF-2-K/Fru-2,6-P2ase 2; 6PF-2-K/Fru-2,6-P2ase heart-type isozyme; DKFZp781D2217; F262; Fructose-2,6-bisphosphatase; fructose-2,6-bisphosphatase, cardiac isozyme; MGC138308; MGC138310; PFK-2/FBPase-2; PFK/FBPase 2; PFKFB, cardiac; PFKFB2
|
Gene Symbols: PFKFB2
|
Molecular weight:
58,477 Da
|
Basal Isoelectric point:
8.61
Predict pI for various phosphorylation states
|
CST Pathways:
PI3K/Akt Signaling
|
Warburg Effect
|
Protein-Specific Antibodies, siRNAs or Recombinant Proteins from Cell Signaling Technology®
|